glp-1 therapy madisonville Medication + Bioidentical Hormone Replacement | Gynecology, Integrative Medicine & Functional Medicine located in Upper East Side, New York, NY GLP-1 Therapy Chicago & Northbrook

& Okuno, Y

SAXENDA was evaluated for safety in 5 double-blind, placebo controlled trials that included 3,384 overweight or obese adult patients treated with SAXENDA for a treatment period up to 56 weeks (3 trials), 52 weeks (1 trial), and 32 weeks (1 trial) and one trial of 56 weeks in 125 pediatric patients with obesity aged 12 years and older [see Clinical Studies (14.1, 14.2)]

Still, these drugs have taken off in popularity in America, as well as around the world

Potential Side Effects and Safety Considerations The most common side effects are gastrointestinal nausea, vomiting, and diarrhoea with additional monitoring warranted for pancreatitis, gallbladder disease, heart rate changes, and diabetic retinopathy